Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis

Therapeutic Hypothermia

(2018) Girija Natarajan et al.   CLINICS IN PERINATOLOGY

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intercenter Cost Variation for Perinatal Hypoxic-Ischemic Encephalopathy in the Era of Therapeutic Hypothermia

(2016) An N. Massaro et al.   JOURNAL OF PEDIATRICS

The long-term health, social, and financial burden of hypoxic-ischaemic encephalopathy

(2015) Paul Eunson   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Bayley-III Cognitive and Language Scales in Preterm Children

(2015) M. M. Spencer-Smith et al.   PEDIATRICS

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

(2015) Scott D. Ramsey et al.   VALUE IN HEALTH

Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990

(2013) Anne CC Lee et al.   PEDIATRIC RESEARCH

Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis

(2011) Alison G. Cahill et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Whole-Body Hypothermia for Term and Near-Term Newborns With Hypoxic-Ischemic Encephalopathy

(2011) Susan E. Jacobs   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy

(2010) Jennifer J. Kurinczuk et al.   EARLY HUMAN DEVELOPMENT

Cost-Effectiveness of Therapeutic Hypothermia to Treat Neonatal Encephalopathy

(2010) Dean A. Regier et al.   VALUE IN HEALTH